From the Department of Ophthalmology (Slabaugh, Bojikian, Moore, Chen), University of Washington, Seattle, Washington; the Department of Ophthalmology (Bojikian), Federal University of São Paulo, São Paulo, Brazil.
From the Department of Ophthalmology (Slabaugh, Bojikian, Moore, Chen), University of Washington, Seattle, Washington; the Department of Ophthalmology (Bojikian), Federal University of São Paulo, São Paulo, Brazil.
J Cataract Refract Surg. 2014 Apr;40(4):538-44. doi: 10.1016/j.jcrs.2013.08.048. Epub 2014 Jan 17.
To evaluate the risk factors for and frequency of an acute intraocular pressure (IOP) elevation (spike) after phacoemulsification in patients with glaucoma.
Academic glaucoma clinics and operating rooms.
Retrospective case series.
Charts of consecutive glaucoma patients without previous incisional glaucoma surgery having phacoemulsification by the same surgeon between August 1996 and July 2012 were reviewed to obtain demographic information, preoperative glaucoma medications, severity and treatment measures, intraoperative course, and postoperative outcomes. A postoperative IOP spike was defined as IOP greater than 50% above baseline IOP. Main outcome measures were the number of eyes with a postoperative IOP spike and risk factors associated with an IOP spike after phacoemulsification.
Of 271 eyes (271 patients) included in the study, 45 (17%) had an IOP spike. Risk factors for postoperative IOP spike by multivariate analysis included longer axial length (AL) or associated characteristics (wider angle grade on gonioscopy, deeper anterior chamber, and male sex), higher number of preoperative IOP-lowering medications, previous laser trabeculoplasty, and lack of postoperative oral acetazolamide. One eye (0.4%) required trabeculectomy during the 90-day postoperative period.
A significant proportion of glaucoma patients having phacoemulsification had an IOP spike. Patients requiring a higher number of IOP-lowering medications or laser trabeculoplasty for IOP control preoperatively and those with a greater AL should be treated more aggressively with IOP-lowering medication in the immediate postoperative period.
No author has a financial or proprietary interest in any material or method mentioned.
评估青光眼患者超声乳化术后急性眼压(IOP)升高( spikes )的危险因素和频率。
学术青光眼诊所和手术室。
回顾性病例系列。
回顾了 1996 年 8 月至 2012 年 7 月间由同一位外科医生进行超声乳化术的连续青光眼患者的图表,以获取人口统计学信息、术前青光眼药物、严重程度和治疗措施、手术过程和术后结果。将术后 IOP 升高定义为 IOP 比基线 IOP 升高超过 50%。主要观察指标是术后 IOP 升高的眼数和与超声乳化术后 IOP 升高相关的危险因素。
在研究的 271 只眼(271 例患者)中,有 45 只眼(17%)出现了 IOP 升高。多变量分析的术后 IOP 升高危险因素包括较长的眼轴(AL)或相关特征(前房角镜检查时更宽的角度分级、更深的前房和男性)、更多的术前降眼压药物、既往激光小梁成形术和术后缺乏口服乙酰唑胺。在术后 90 天内,有 1 只眼(0.4%)需要行小梁切除术。
相当一部分青光眼患者行超声乳化术后出现 IOP 升高。术前需要更多的降眼压药物或激光小梁成形术控制眼压的患者以及 AL 较长的患者,在术后应更积极地使用降眼压药物。
没有作者在提到的任何材料或方法上有财务或所有权利益。